"Last week, Brazil’s pharma industry regulatory agency, the
National Agency of Sanitary Surveillance (ANVISA), announced that they were “suspending” at least part of RDC-54/2013, the declaration that mandated drug serialization and tracing, until further notice. Thank you to all who forwarded
the link to the official announcement. I was able to translate and read it on Thursday, and I submitted a comment on my own last essay, “
Pharma Serialization Deadlines In Flux“, to include the link. Apparently shortly after that essay was published, ANVISA
publicly announced the suspension."
Dirk Rodgers - Read the full article from Dirk here.
No comments:
Post a Comment